COVID-19 mRNA vaccines safe to use during pregnancy, study finds
Four percent more unvaccinated pregnant women had health complications than pregnant women who received the mRNA vaccine against COVID-19 after a week in a new study.
Vials representing the mRNA coronavirus disease (COVID-19) vaccine candidate developed by Sinopharm's China National Biotec Group (CNBG) are seen displayed at its booth at the 2021 China International Fair for Trade in Services (CIFTIS) in Beijing, China September 3, 2021.(photo credit: REUTERS/FLORENCE LO)ByJERUSALEM POST STAFFUpdated:
